Market Cap (In USD)
7.56 Million
Revenue (In USD)
895.47 Thousand
Net Income (In USD)
-26.29 Million
Avg. Volume
1.73 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.18-7.95
- PE
- -
- EPS
- -
- Beta Value
- 0.076
- ISIN
- NL0015000LC2
- CUSIP
- N5436L101
- CIK
- 1874252
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Guido Baechler
- Employee Count
- -
- Website
- https://mainzbiomed.com
- Ipo Date
- 2021-11-05
- Details
- Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
More Stocks
-
ESAUESGold Corp.
ESAU
-
000670Infotmic Co., Ltd.
000670
-
GLOSTERLTDGloster Limited
GLOSTERLTD
-
NOVAAGRINova Agritech Limited
NOVAAGRI
-
600433
-
RVTI
-
SRTOY
-
6879IMAGICA GROUP Inc.
6879